Gdansk, Poland

Alicja Ziemienowicz

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alicja Ziemienowicz. Retrieved from https://idiyas.com/inventor/alicja-ziemienowicz-x3d1pgel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alicja Ziemienowicz: Innovator in Animal Cell Transformation

Introduction

Alicja Ziemienowicz is a prominent inventor based in Gdansk, Poland. She has made significant contributions to the field of biotechnology, particularly in the transformation of animal cells. Her innovative methods have the potential to advance research and applications in various biological sciences.

Latest Patents

Alicja holds a patent for a "Method for transformation of animal cells." This invention relates to a method for introducing nucleic acids into cells, which can be used for producing transiently transfected or stably transformed animal cells. The method utilizes a specifically designed nucleic acid/protein complex that includes a VirD2 protein, preferably in conjunction with a VirE2 protein.

Career Highlights

Alicja Ziemienowicz is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in biotechnology.

Collaborations

Some of her notable coworkers include Biserka Relic and Barbara Hohn. Their collaborative efforts have further enhanced the impact of their research and innovations in the field.

Conclusion

Alicja Ziemienowicz's contributions to the transformation of animal cells exemplify her dedication to advancing biotechnology. Her innovative methods and collaborations continue to influence the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…